RekrutujeFaza II/III
Ruxolitinib for childhood ALL in Poland (Rux-cALL-Pol 2020 trial) - Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 Poland or AIEOP-BFM 2017 standard of care…
Miasta: Białystok, Bydgoszcz, Gdańsk, Katowice i 11 innych miastWiek: do 17.99 latSponsor: Medical University Of Lodz
W Polsce: Rekrutacja zakończonaNa świecie: RekrutujeFaza III
International phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy…
Miasta: Białystok, Bydgoszcz, Gdańsk, Katowice i 11 innych miastWiek: do 64 latSponsor: Universita Degli Studi Di Milano Bicocca
RekrutujeFaza III
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
Miasta: WarszawaWiek: do 64 latSponsor: GPOH gGmbH
W Polsce: Wkrótce rekrutacjaNa świecie: RekrutujeFaza I/II
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
Miasta: WrocławWiek: do 17.99 latSponsor: F. Hoffmann-La Roche AG
RekrutujeFaza III
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Miasta: WarszawaWiek: od 18 latSponsor: European Organisation For Research And Treatment Of Cancer